Literature DB >> 7883659

Treatment of visceral Leishmaniasis unresponsive to pentamidine with amphotericin B.

O P Giri.   

Abstract

Twenty five cases of visceral leishmaniasis unresponsive to Pentamidine were treated with Amphotericin B in the dose schedule of 0.75 mg per kg body weight I.V. on alternate days for total 15 infusions. Full cure was achieved in all twenty five (hundred per cent) cases, no significant toxicity was observed during as well as after treatment and none of the patients relapsed during twelve months follow-up.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7883659

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  6 in total

1.  Use of Leishmania donovani field isolates expressing the luciferase reporter gene in in vitro drug screening.

Authors:  Suman Gupta; Shyam Sundar; Neena Goyal
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

2.  Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion.

Authors:  Mireille Basselin; Hubert Denise; Graham H Coombs; Michael P Barrett
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

3.  MANAGEMENT OF KALA AZAR - AN UPDATE.

Authors:  S P Kalra; A Bahl; Lt Col Pc Sanchetee; S K Dham
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 4.  Therapeutic options for visceral leishmaniasis.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

5.  A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India.

Authors:  Vidya Nand Rabi Das; Niyamat Ali Siddiqui; Krishna Pandey; Vijay Pratap Singh; Roshan K Topno; Dharmendra Singh; Rakesh Bihari Verma; Alok Ranjan; Prabhat Kumar Sinha; Pradeep Das
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

Review 6.  Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective.

Authors:  Om Prakash Singh; Bhawana Singh; Jaya Chakravarty; Shyam Sundar
Journal:  Infect Dis Poverty       Date:  2016-03-08       Impact factor: 4.520

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.